Trial Profile
A Rising Single Oral Dose Study to Investigate the Tolerability, Pharmacokinetics and Dopamine ß-hydroxylase (DßH) Inhibition Profile of BIA 5-453 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Etamicastat (Primary)
- Indications Hypertension
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Bial
- 01 Aug 2016 New trial record